CARDIOTROPIC PREPARATION Russian patent published in 1995 - IPC

FIELD: medicine, particularly, cardiology. SUBSTANCE: this preparation includes 10.9 to 15.6 percent by mass cytochrome, 0.5 to 0.56 percent by mass nicotinamide adeninedinucleotide, 82.8 to 88.03 percent by mass inosine (rhiboxine), 0.33 to 1.02 percent by mass oxyfedrine, and 0.07 to 0.2 percent by mass beta-acetyldigoxin. Disclosed preparation is employed for simultaneously harmonically normalizing performance of all three cardiomyocyte systems responsible for contraction/relaxation and recovery of ultrastructure of myocardial cells exposed to destructive affection during inflammatory lesion of myocardium and terminal phases of cardiac insufficiency of noninflammatory character. EFFECT: two-day cure involving administration of disclosed preparation allows normalizing peripheral and intracardiac hemodynamic characteristics, recovery of systolic and diastolic functions of myocardium, coordination of these functions, and elimination of blood congestion both in lungs and liver.